Status
Conditions
Treatments
About
This study is hypothesis-generating to explore the impact of JAK2 (V617F) mutation status on the treatment response to anagrelide hydrochloride
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
47 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal